// App-Quantinova.ai

TCT-345 : Functional Status after Transcatheter and Surgical Aortic Valve Replacement: A Two-Year Analysis from the SURTAVI Trial

Researchers

Presenter

  • Jeffrey J. Popma

Principal Investigators

  • Nicolas Van Mieghem

  • Michael J. Reardon

  • A. Pieter Kappetein

  • Steven Yakubov

  • G. Michael Deeb

  • Stanley Chetcuti

  • Mubashir Mumtaz

  • Hemal Gada

  • William Merhi

  • John Heiser

  • Patrick Serruys

Medical Centers

  • Riverside Methodist Hospital, Columbus, Ohio, United States

  • Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, United States

  • Thorax Center, Erasmus Medical Center, Rotterdam, Netherlands

  • Imperial College, London, United Kingdom

  • Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands

  • University of Michigan Hospitals, Ann Arbor, Michigan, United States

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

  • West Michigan Cardiothoracic Surgeons (WMCTS), Grand Rapids, Michigan, United States

  • PinnacleHealth CardioVascular Institute, Wormleysburg, Pennsylvania, United States

  • PinnacleHealth, Harrisburg, Pennsylvania, United States

Locations

  • United States

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Severe Aortic Stenosis

  • Heart muscle disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved